Search - tctmd.com

Displaying 41 - 60 of 67

Sort: Relevancy | Date

News Conference News ESC 2014

ESC Congress 2014: Positive, Negative Findings Come on Background of Improving Outcomes Overall

Todd Neale

September 08, 2014

Presentation ESC 2014

Two- year clinical outcome of post procedural mitral regurgitation after transcatheter aortic valve replacement

Presenter: Biner S. Finkelstein

September 03, 2014

News Conference News ESC 2014

Mitral Regurgitation Associated with Decreased Survival in TAVR Patients

Yael L. Maxwell

September 03, 2014

Presentation ESC 2014

Is TAVR the treatment of choice for high risk diabetic patients with aortic stenosis? Insights from the FRANCE2 Registry

Presenter: Eric Van Belle

September 02, 2014

News Conference News ESC 2014

GARY: Transapical TAVR Appears Inherently Riskier Than Transvascular

Caitlin E. Cox

September 02, 2014

News Conference News ESC 2014

FRANCE2: Registry Shows Positive Outcomes for TAVR in High-Risk Diabetic Patients

Yael L. Maxwell

September 02, 2014

News Conference News ESC 2014

Single-Center Study Compares TAVR Devices in Mixed Aortic Stenosis

Caitlin E. Cox

August 31, 2014

News Conference News ESC 2014

Registry Outcomes Match Positive Trial Findings for Repositionable TAVR Device

Todd Neale

August 31, 2014

News Conference News ESC 2013

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

September 09, 2013

News Conference News ESC 2013

PARTNER A: TAVR the Optimal Choice for Diabetic Patients at High Risk

Yael L. Maxwell

September 04, 2013

News Conference News ESC 2013

Usefulness of IABP Questioned in MI Patients with Cardiogenic Shock

Yael L. Maxwell

September 03, 2013

Presentation ESC 2013

Transcatheter versus Surgical Aortic Valve Replacement in Patients with Diabetes and Severe Aortic Stenosis at High Risk for Surgery: PARTNER I, High-risk Cohort

Presenter: Brian R. Lindman

September 03, 2013

News Conference News ESC 2013

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

Caitlin E. Cox

September 03, 2013

News Conference News ESC 2013

FRANCE 2: Post-TAVR Aortic Regurgitation Doubles Mortality Risk

Caitlin E. Cox

September 02, 2013

News Conference News ESC 2012

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Caitlin E. Cox

September 04, 2012

News Conference News ESC 2012

French, European Registries Add International Flavor to TAVR Assessment

August 29, 2012

News Conference News ESC 2012

TAVR Improves Quality of Life, Reduces Hospitalization in German Registry

Yael L. Maxwell

August 28, 2012

Presentation ESC 2012

Early Experience With the JenaValve™ Transapical Aortic Valve Implantation System

Presenter: Markus Ferrari

August 28, 2012

News Conference News ESC 2012

Dedicated Transapical TAVR Device Shows Promise in Premarket Clinical Research

Caitlin E. Cox

August 28, 2012

News Conference News ESC 2012

Registries Show Strides for Transcatheter Valve Treatments in Europe

Caitlin E. Cox

August 27, 2012

Advertisement

ESC Congress 2014: Positive, Negative Findings Come on Background of Improving Outcomes Overall

Two- year clinical outcome of post procedural mitral regurgitation after transcatheter aortic valve replacement

Mitral Regurgitation Associated with Decreased Survival in TAVR Patients

Is TAVR the treatment of choice for high risk diabetic patients with aortic stenosis? Insights from the FRANCE2 Registry

GARY: Transapical TAVR Appears Inherently Riskier Than Transvascular

FRANCE2: Registry Shows Positive Outcomes for TAVR in High-Risk Diabetic Patients

Single-Center Study Compares TAVR Devices in Mixed Aortic Stenosis

Registry Outcomes Match Positive Trial Findings for Repositionable TAVR Device

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

PARTNER A: TAVR the Optimal Choice for Diabetic Patients at High Risk

Usefulness of IABP Questioned in MI Patients with Cardiogenic Shock

Transcatheter versus Surgical Aortic Valve Replacement in Patients with Diabetes and Severe Aortic Stenosis at High Risk for Surgery: PARTNER I, High-risk Cohort

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

FRANCE 2: Post-TAVR Aortic Regurgitation Doubles Mortality Risk

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

French, European Registries Add International Flavor to TAVR Assessment

TAVR Improves Quality of Life, Reduces Hospitalization in German Registry

Early Experience With the JenaValve™ Transapical Aortic Valve Implantation System

Dedicated Transapical TAVR Device Shows Promise in Premarket Clinical Research

Registries Show Strides for Transcatheter Valve Treatments in Europe

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content